Takeda Pharmaceuticals has been dealt another setback in its quest to gain U.S. approval of its diabetes drug alogliptin and a combo tablet that combines the developmental compound with the blockbuster diabetes pill Actos. The FDA has delayed review of…
Archive for the ‘Actos’ Category
FDA delays review of key Takeda diabetes drug, Actos combo
November 18th, 2011 
Ryan McBride 
Posted in Actos, Blog, Companies, Diagnostics, FDA, Funding, Medical Devices, Medical Supply, Pharmaceuticals, Startups, Takeda, Universities, Videos 
Comments Off